PT Enseval Putera Megatrading Terbuka operates in the Drugs, proprietaries, and sundries sector.
In addition to historical fundamental analyses, the complete report available to purchase compares PT Enseval Putera Megatrading Terbuka with three other
drug stores in Asia:
China National Medicines Corp., Ltd.
sales of 8.59 billion Chinese Renmimbi [US$1.38 billion]
of which 98%
was Merchandise Selling),
China Medicine Health Industry Co Ltd
(9.90 billion Chinese Renmimbi [US$1.59 billion]
of which 58%
was International Trade), and
Chuo Bussan Corporation
based in Japan
(129.36 billion Japanese Yen [US$1.27 billion]
of which 99%
was Daily Necessities an).
PT Enseval Putera Megatrading Terbuka reported sales of 13.37 trillion Indonesian Rupiahs (US$1.17 billion)
December of 2012.
increase of 26.0%
versus 2011, when the company's sales were 10.61 trillion Indonesian Rupiahs.
Sales at PT Enseval Putera Megatrading Terbuka have increased during each of the previous five years
(and since 2007, sales have increased a total of 110%).
Sales of Consumer Products saw an increase
37.1% in 2012, from
4.20 trillion Indonesian Rupiahs to 5.76 trillion Indonesian Rupiahs.